Institutional investors purchased a net $520.8 thousand shares of ACOR during the quarter ended September 2015 and now own 110.98% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINT72 ASSET MANAGEMENT LP Bought 1.1 Million shares of Acorda Therapeutics Inc
SCOPIA CAPITAL MANAGEMENT LP Bought 567.3 Thousand shares of Acorda Therapeutics Inc